Floatz logo

Iadademstat

Extensive Stage Lung Small Cell Carcinoma

Yale UniversitySmall moleculePhase 2Active
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
51/ 100
Competitive Position
89/ 100

Competitive context

290 Active assets in the Extensive Stage Lung Small Cell Carcinoma cohort.

Asset / SponsorPhaseRating
Benmelstobart
Yayi He
Phase 4A
vx-970
National Cancer Institute (NCI)
Phase 2BBB
Adebelimab
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 3BBB
Veliparib
Central European Society for Anticancer Drug Research
Phase 2BB
hs-20093
Shanghai Hansoh Biomedical Co., Ltd
Phase 3BB

View all 50 →

Same molecule, other indications

Iadademstat is also rated in:

neuroendocrine carcinomaDormant
CCC
Indicative ·
53 / 100
View asset →
lung cancerDormant
CC
Indicative ·
45 / 100
View asset →
Myelodysplastic Syndrome/Acute Myeloid LeukemiaDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →